A paper by Westrich et al. (2023) examines payer perceptions of 5 totally different worth frameworks. Worth frameworks of curiosity included:
- American Society of Scientific Oncology (ASCO) Worth Framework,
- Drug Pricing Lab’s Drug Abacus (previously Memorial Sloan Kettering Most cancers Heart’s Drug Abacus),
- Institute for Scientific and Financial Overview (ICER) worth evaluation framework and proof reviews
- The Innovation and Worth Initiative (IVI)’s Open-Supply Worth Undertaking fashions,
- Nationwide Complete Most cancers Community (NCCN)’s Proof Blocks
The authors carried out a double-blind, web-based survey to evaluate payers’ perceptions of those worth frameworks. General, 51 well being care payer respondents discovered that the an important elements when choosing a worth framework was that (i) applicable metrics and outcomes had been included, (ii) comparative scientific effectiveness info was supplied and (iii) the outcomes had been methodologically rigorous and unbiased.
Among the many 5 worth frameworks, ICER, NCCN and ASCO had been the worth frameworks thought-about most helpful for formulary selections, whereas ICER was far and away probably the most helpful for drug worth negotiations.
